Annual CFF
$2.08 M
+$8.45 M+132.69%
31 March 2023
Summary:
Nemaura Medical annual cash flow from financing activities is currently $2.08 million, with the most recent change of +$8.45 million (+132.69%) on 31 March 2023. During the last 3 years, it has fallen by -$35.90 million (-94.52%). NMRD annual CFF is now -94.52% below its all-time high of $37.99 million, reached on 31 March 2021.NMRD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$3.00 M
-$6.92 M-176.50%
31 December 2023
Summary:
Nemaura Medical quarterly cash flow from financing activities is currently -$3.00 million, with the most recent change of -$6.92 million (-176.50%) on 31 December 2023. Over the past year, it has dropped by -$6.92 million (-176.50%). NMRD quarterly CFF is now -116.21% below its all-time high of $18.51 million, reached on 31 March 2021.NMRD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$2.68 M
-$1.30 M-32.69%
31 December 2023
Summary:
Nemaura Medical TTM cash flow from financing activities is currently $2.68 million, with the most recent change of -$1.30 million (-32.69%) on 31 December 2023. Over the past year, it has dropped by -$1.30 million (-32.69%). NMRD TTM CFF is now -92.95% below its all-time high of $37.99 million, reached on 31 March 2021.NMRD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMRD Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -176.5% | -32.7% |
| 3 y3 years | -94.5% | -30.4% | -84.6% |
| 5 y5 years | +1.6% | -100.0% | +20.7% |
NMRD Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -94.5% | +132.7% | -156.0% | +16.7% | -84.6% | +133.9% |
| 5 y | 5 years | -94.5% | +132.7% | -116.2% | +16.7% | -93.0% | +133.9% |
| alltime | all time | -94.5% | +132.7% | -116.2% | +16.7% | -93.0% | +133.9% |
Nemaura Medical Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | - | -$3.00 M(-176.5%) | $2.68 M(-32.7%) |
| Sept 2023 | - | $3.92 M(-208.9%) | $3.98 M(-375.6%) |
| June 2023 | - | -$3.60 M(-167.2%) | -$1.44 M(-169.3%) |
| Mar 2023 | $2.08 M(-132.7%) | $5.36 M(-415.1%) | $2.08 M(-133.5%) |
| Dec 2022 | - | -$1.70 M(+13.3%) | -$6.22 M(-12.5%) |
| Sept 2022 | - | -$1.50 M(+1918.8%) | -$7.11 M(-10.1%) |
| June 2022 | - | -$74.30 K(-97.5%) | -$7.91 M(+24.2%) |
| Mar 2022 | -$6.37 M(-116.8%) | -$2.95 M(+14.0%) | -$6.37 M(-142.2%) |
| Dec 2021 | - | -$2.59 M(+12.4%) | $15.08 M(-13.2%) |
| Sept 2021 | - | -$2.30 M(-257.1%) | $17.37 M(-46.5%) |
| June 2021 | - | $1.46 M(-92.1%) | $32.49 M(-14.5%) |
| Mar 2021 | $37.99 M(>+9900.0%) | $18.51 M(-6268.7%) | $37.99 M(+95.4%) |
| Dec 2020 | - | -$300.00 K(-102.3%) | $19.44 M(-1.4%) |
| Sept 2020 | - | $12.82 M(+84.3%) | $19.71 M(+186.2%) |
| June 2020 | - | $6.96 M(<-9900.0%) | $6.89 M(+6984.4%) |
| Mar 2020 | $97.20 K(-95.3%) | -$43.50 K(+54.3%) | $97.20 K(+77.0%) |
| Dec 2019 | - | -$28.20 K(<-9900.0%) | $54.90 K(-97.5%) |
| Sept 2019 | - | $0.00(-100.0%) | $2.22 M(-0.0%) |
| June 2019 | - | $168.90 K(-296.9%) | $2.22 M(+8.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | $2.05 M(>+9900.0%) | -$85.80 K(-104.0%) | $2.05 M(-4.0%) |
| Dec 2018 | - | $2.14 M(>+9900.0%) | $2.14 M(>+9900.0%) |
| Sept 2018 | - | $500.00(>+9900.0%) | $500.00(>+9900.0%) |
| June 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2017 | $0.00(-100.0%) | - | - |
| Mar 2016 | $10.30 M(>+9900.0%) | $59.70 K(-99.4%) | $10.30 M(+0.6%) |
| Dec 2015 | - | $9.98 M(+3820.3%) | $10.24 M(+3920.3%) |
| Sept 2015 | - | $254.70 K(>+9900.0%) | $254.70 K(>+9900.0%) |
| Mar 2015 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2014 | - | $0.00(0.0%) | $265.50 K(0.0%) |
| Sept 2014 | - | $0.00(0.0%) | $265.50 K(0.0%) |
| June 2014 | - | $0.00(-100.0%) | $265.50 K(0.0%) |
| Mar 2014 | $265.50 K | $265.50 K(>+9900.0%) | $265.50 K(>+9900.0%) |
| Dec 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2013 | - | $0.00 | $0.00 |
FAQ
- What is Nemaura Medical annual cash flow from financing activities?
- What is the all time high annual CFF for Nemaura Medical?
- What is Nemaura Medical quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Nemaura Medical?
- What is Nemaura Medical quarterly CFF year-on-year change?
- What is Nemaura Medical TTM cash flow from financing activities?
- What is the all time high TTM CFF for Nemaura Medical?
- What is Nemaura Medical TTM CFF year-on-year change?
What is Nemaura Medical annual cash flow from financing activities?
The current annual CFF of NMRD is $2.08 M
What is the all time high annual CFF for Nemaura Medical?
Nemaura Medical all-time high annual cash flow from financing activities is $37.99 M
What is Nemaura Medical quarterly cash flow from financing activities?
The current quarterly CFF of NMRD is -$3.00 M
What is the all time high quarterly CFF for Nemaura Medical?
Nemaura Medical all-time high quarterly cash flow from financing activities is $18.51 M
What is Nemaura Medical quarterly CFF year-on-year change?
Over the past year, NMRD quarterly cash flow from financing activities has changed by -$6.92 M (-176.50%)
What is Nemaura Medical TTM cash flow from financing activities?
The current TTM CFF of NMRD is $2.68 M
What is the all time high TTM CFF for Nemaura Medical?
Nemaura Medical all-time high TTM cash flow from financing activities is $37.99 M
What is Nemaura Medical TTM CFF year-on-year change?
Over the past year, NMRD TTM cash flow from financing activities has changed by -$1.30 M (-32.69%)